Skip to content

Mooy Pharma

Active Private limited companyfounded 2012active for 14 yearsZuidstraat 18, 8630 VeurneKBO/BCE: BE 0846.742.494

Lifetime

13 annual accounts with figures on one time axis
peak of €323,835 in 2025
€323,835▲ 32.5%
lowest -€108,069 in 2013
€145,608▲ €172,834
peak of €365,338 in 2025
€365,338▲ 65.0%
€1.4m▼ 8.8%
peak of 1.2 FTE in 2025
1.2 FTE▲ 33.3%
Board2 names since 2012
2 directors and 1 other
Documentsfilings and deeds
24-07-20267 days before the deadline
2025abbreviated format
Gross margin from €244,457 to €323,835Profit of €145,608, after a lossStaff from 0.9 FTE to 1.2 FTERegistered office moved from De Panne to Veurne 18-04Dividend €1,666Equity from €221,396 to €365,338

Key points

from the 2025 annual accounts

Equity

€365,338 ▲ 65.0%
221,3962024+145,608Profit-1,666Dividend365,3382025

Mooy Pharma paid out €1,666 in dividends. That is 1% of the 2025 profit.

Result

€145,608 €145,608
-€27,2002024€146,0002025

Back in profit in 2025, after a loss of €27,227 in 2024.

Debts

€1.4m 79% of the balance sheet
Financial debts 64%Suppliers 7%Taxes and wages 3%Other 25%

€801,131 of the debts are secured on the company's own assets.

Staff

1 employees on 31-12-2025
102024112025

In 2025, 1 employee joined and 1 left.

Liquidity

1.55 was 1.01 in 2024

Short-term debts fell from €723,437 to €486,663.

Filings

13 annual accounts since 2013
AprilJune31 JulyOctober201520202025

Nine of the last ten came late. The 2017 accounts came in latest, 45 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 5,052 companies had the same profile as Mooy Pharma has now. Each dot stands for 13 companies, two years later.

95.8%
were still trading
2.4%
stopped another way
1.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 5,052 companies, not a prediction for Mooy Pharma. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 21-06-2012
Manager, since 21-06-2012
  • 200 sharesdeed of 25-06-2012
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0846742494
Registered office moved from De Panne to Veurne The registered office moved from Groene-Biezenlaan 46, 8660 De Panne to Zuidstraat 18, 8630 Veurne · Board meeting of 27-02-2025 · Gazette deed
Environmental permit granted Build or rebuild, Outbuildings, Demolish · decided by Veurne
Publication in the Belgian Official Gazette Gazette deed
All 27 events

Comparable companies

same main activity, similar in size and age
Company
Mooy Pharma Veurne €1.7m €323,835 21.0% 1.2
APOTHEEK KALVEKEETDIJK Knokke-Heist €1.6m €319,774 38.5% 1
QARDEA Oostkamp €1.8m €357,789 41.6% 1
LA+PHARMA Houthulst €1.4m €359,945 42.6% 0.9
Apotheek Charlotte De Splenter Etikhove Maarkedal €1.8m €257,633 36.6% 1
APOTHEEK BEIGEM Grimbergen €1.6m €359,539 11.7% 1.6
Apotheek Heleen Mylle Anzegem €1.6m €425,383 33.8% 1

These companies have the same main activity as Mooy Pharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.4m and €1.8m, founded between 2008 and 2012.

Official details

Source: KBO
Status
Active since 21-06-2012Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.212.435.4858630 Veurne, registered on 05-07-2012
Financial year end
31 December
Peppol
Reachable since 16-05-2025
Company details

Annual accounts 2025

≈ €1.1mestimated
€1.7m▲ 0.7%
Employeeson 31-12-2025
1=
Filing
Filed on 24-07-2026, 7 days before the end of the filing period
Financials

Insights on Mooy Pharma

Mooy Pharma files the abbreviated format. That format states no turnover. The gross margin rose from €84,135 in 2013 to €323,835 in 2025.

The balance sheet grew most from 2024 to 2025 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Mooy Pharma

What is the company number of Mooy Pharma?
The company number of Mooy Pharma is 0846.742.494. The VAT number is the same number with BE in front: BE 0846.742.494.
Where is Mooy Pharma based?
The registered office is at Zuidstraat 18, 8630 Veurne.Company details
What does Mooy Pharma do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Mooy Pharma?
Mooy Pharma is a private limited company (BV).
When was Mooy Pharma founded?
Mooy Pharma was founded on 21-06-2012.
Is Mooy Pharma still active?
Yes, Mooy Pharma is an active enterprise in the KBO register.
How many employees does Mooy Pharma have?
Mooy Pharma had an average of 1.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Mooy Pharma fall under?
In its 2025 annual accounts, Mooy Pharma states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of Mooy Pharma?
The turnover in financial year 2025 is about €1.1m. This figure is estimated from the gross margin of €323,835 and 42 comparable companies (NACE 477). It probably lies between €880,000 and €1.5m.
Is Mooy Pharma profitable?
In financial year 2025, Mooy Pharma made a profit of €145,608.
Where can I find the annual accounts of Mooy Pharma?
Mooy Pharma filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Mooy Pharma due?
Mooy Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.